Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (12) Remove All (12) filter
  • News & Articles (4)
  • Research (4)
  • Researcher Profiles (4)

Search found 12 items

All
Self-injecting pen for asthma drug gets PBS support
Category: News & Articles
... with severe eosinophilic asthma patients to self-administer a drug known as Mepolizumab, with reimbursement under the PBS. A new ... allow patients with severe eosinophilic asthma to self-administer a drug known as NUCALA (Mepolizumab), with Pharmaceutical Benefits Scheme ... at the University of Newcastle and HMRI, access to new self-administration options for severe eosinophilic asthma is a timely and ...
Pregnancy & Babies
Category: Research

In Australia, approximately 8% of all babies are born preterm (before 37 completed weeks of gestation). That’s about 25,000 babies every year born premature in Australia. (Australian Institute of Health and Welfare - 2011)

Unfortunately, despite the high prevalence of preterm birth, the causes are still largely unknown. Researchers at the Mothers and Babies Research Centre are working to improve the understanding of human pregnancy and what can cause problems to arise, potentially leading to premature birth.

COVID-19 nasal spray moves to Phase 2 study
Category: News & Articles

Encouraging preliminary results from an ongoing phase 1 study have triggered the announcement of phase 2 studies for a first-in-class nasal spray to protect people from respiratory viral diseases such as COVID-19 and influenza.

Anoop Enjeti
Category: Researcher Profiles
... support funding including a recent NHMRC Ideas grant exploring novel drug targets in leukemia.  He has received over 3 million dollars in ... discovery that Venotoclax was a viable effective oral anti-leukemic drug. The results of this trial, led by Dr Enjeti at the Calvary Mater ... as part of an International effort, has led to the US Food and Drug Administration considering this drug in older leukemia patients which ...
Jonathan Paul
Category: Researcher Profiles
What are your research interests? Development of a targeted drug delivery system for the uterus to ensure that drugs given to women ... and labour. Dr Paul is part of a team that has developed a targeted drug delivery system for the uterus and was recently selected to present ... (proteomics) In vivo laboratory studies (handling, monitoring, administration of substances) In vivo imaging Affiliations Mothers and ...
The effects of dopamine and droperidol on the cardiorespiratory responses to severe hypoxaemia
Category: Research
... to these reflex mechanisms before and during dopamine or droperidol administration, it will be possible to assess not only the mechanisms of ... The aim is to characterise the effect of increasing doses of each drug on the integrated cardiorespiratory responses to hypoxia in the ...
HMRI leading a coordinated approach to clinical trials on COVID-19
Category: News & Articles
... trial, with patients being randomly selected to receive either the drug Lopinavir-Ritonavir, which is currently used to treat HIV, a ... that new drugs can be added if they show promise. Similarly, if a drug doesn’t appear effective or causes severe side effects it can be ... many elements and challenges to it, the design, the governance, the administration, the recruitment, data collection and analysis, not to ...
Nicole Ryan
Category: Researcher Profiles
... and laboratory data. Determining the effectiveness of early antivenom administration compared to current snake bite guidelines. Investigating ...
The effects of sevoflurane on the cardiorespiratory responses to severe hypoxaemia
Category: Research
... that occur to these reflex mechanisms before and during sevoflurane administration, it will be possible to assess not only the mechanisms of action of this drug, but further the role of chemoreflexes during surgical procedures ...
Left atrium volume and deformation in preterm infants
Category: Research
... and chronic lung disease of prematurity. Treatment for a PDA is administration of non-steroidal anti-inflammatory drugs. This treatment ...
  • 1
  • 2
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services